wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37844529-E0712C47-5948-4C7F-8EC1-CD7B3AD49DAE
Q37844529-E0712C47-5948-4C7F-8EC1-CD7B3AD49DAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37844529-E0712C47-5948-4C7F-8EC1-CD7B3AD49DAE
A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer.
P2860
Q37844529-E0712C47-5948-4C7F-8EC1-CD7B3AD49DAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37844529-E0712C47-5948-4C7F-8EC1-CD7B3AD49DAE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
57ba75bd41dc2e00bd8b1b52e84ceaf13ff900f7
P2860
Erlotinib in advanced non-small cell lung cancer: efficacy and safety findings of the global phase IV Tarceva Lung Cancer Survival Treatment study.